Dr. Vince Clinical Research (DVCR), a fast-growing contract research organization (CRO), is proud to announce the official ...

The global medical writing market is projected to grow from USD 4.66 billion in 2024 to USD 12.12 billion by 2033, with a CAGR of 11.20% from 2025 to 2033. This growth is driven by the expansion of ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

Mind Medicine is perhaps the best positioned stock in the psychedelics space, but it is important to remember that the whole ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that the ...

Platform was spotlighted by Dr. Amir Horowitz at ASGCT 2025 for its approach to targeting the HLA-E/NKG2A axis to selectively activate NK and CD8+ T cells, potentially addressing treatment resistance.

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The Company is developing a platform of novel drugs ...